Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that management will be attending TD Cowen's 45th Annual ...

Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that its management team will be attending the TD Cowen's 45th Annual Health Care Conference on Monday, March 3 ...

Good day, and welcome to the Youdao 2024 fourth quarter and full year earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr.

Q4 2024 Earnings Conference Call February 20, 2025 5:00 AM ETCompany ParticipantsJeffrey Wang - Investor Relations DirectorFeng ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 ...

Temple Kol Ami’s Director of Education and Engagement, Carly Kastner, was honored with the title of “Reform Jewish Educator” ...

Columbia’s campus has been engulfed in protests, inflammatory rhetoric, and an unsettling surge of antisemitism.

Q4 2024 Earnings Call Transcript February 20, 2025 NetEase, Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.77. Operator: Good day and welcome to the NetEase 2024 Fourth ...

Opus Genetics (IRD) announced that the first pediatric patient was dosed in its ongoing Phase 1/2 clinical trial evaluating OPGx-LCA5, its ...

Mahe, Seychelles, Feb. 17, 2025 (GLOBE NEWSWIRE) -- BitMart, a leading global cryptocurrency exchange, is excited to unveil its monthly Key Opinion Leader (KOL) Incentive Campaign, a unique ...

The 2024/25 UEFA Conference League began on 2 October and concludes with the final on 28 May 2025.

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...